<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Immunology and Molecular Pathology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F1979EE4-A9E3-4657-94AD-BB70CDEBBD15"><gtr:id>F1979EE4-A9E3-4657-94AD-BB70CDEBBD15</gtr:id><gtr:firstName>Lucy</gtr:firstName><gtr:surname>Walker</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802382"><gtr:id>C9D8B7D3-2DFC-4192-9E50-B570175C22F1</gtr:id><gtr:title>CD4 T cell differentiation and regulation in autoimmune diabetes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802382</gtr:grantReference><gtr:abstractText>Type 1 diabetes is an autoimmune disease in which cells of the immune system attack the pancreas and prevent it from producing insulin. Even if new insulin-producing cells are provided as a transplant, the immune system simply destroys these too. Medicines are available that suppress the entire immune system, but these have unwanted side effects. The key to successful treatment of type 1 diabetes is to pinpoint which cells cause disease so that these can be selectively targeted. We have performed a screen to characterise the immune cells that cause diabetes in a mouse model. This work has yielded a striking result; the cells are quite clearly a particular subset called follicular helper T cells. The possibility that this subset of immune cells could cause diabetes has not previously been explored. The proposed work seeks to investigate how these cells develop, and determine whether targeting this subset therapeutically can prevent or reverse diabetes. We will explore whether follicular helper T cells can be detected in blood samples from type 1 diabetes patients and will also take advantage of mouse diabetes models so we can test whether targeting these cells has beneficial effects.</gtr:abstractText><gtr:technicalSummary>The importance of CD4 T cells in driving autoimmune diabetes has been recognised for some time. According to the original Th1/Th2 paradigm of CD4 T cell differentiation, diabetes was initially attributed to the Th1 subset. However, numerous subsequent observations appear at odds with this conclusion. Recent work has highlighted the potential for additional lineage choices for CD4 T cells, including the capacity to become Th17 cells, follicular helper T (TFH) cells or even Treg. Microarray data obtained using our TCR transgenic model of diabetes suggest the novel possibility that the T cells responsible for this autoimmune disease are TFH cells, the subset that specialises in providing B cell help. The proposed experiments will elucidate the molecular control of TFH cell differentiation and test the hypothesis that these cells play a causal role diabetes. The work will also explore our recent finding that IL-21, the signature cytokine for TFH cells, can counteract Treg suppression, potentially rendering this subset un-suppressible. Collectively our studies will provide new insight into the cellular and molecular pathways that influence CD4 cell differentiation and homeostasis in the context of an autoimmune response. Extending this work directly into human disease, this project will enumerate cells bearing TFH markers in patients with type 1 diabetes (T1D) and ascertain the value of such proteins as biomarkers of disease onset and progression. These studies have the potential to identify new therapeutic targets for the treatment of autoimmune diabetes. Taken together, this proposal constitutes an integrated programme of work that takes advantage of transgenic and gene-deficient mouse strains to generate refined hypotheses for testing in T1D patients. Ongoing iteration between murine and human work will enrich both areas of research and will maximise our progress in understanding the immunological abnormalities underlying autoimmune diabetes.</gtr:technicalSummary><gtr:fund><gtr:end>2016-03-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2575498</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Immune Regulation</gtr:department><gtr:description>MRC Centre Collaboration</gtr:description><gtr:id>E54FEE97-37E8-484B-8D88-C1D902A0592D</gtr:id><gtr:impact>All of the publications produced by my group have been supported by the infrastructure of the MRC Centre for Immune Regulation. This reflects not just support for facilities (eg cell sorting) but also interaction and scientific discussion between colleagues within the Centre.</gtr:impact><gtr:outcomeId>BH3yFAMx4s3-1</gtr:outcomeId><gtr:partnerContribution>Provision of PhD studentships and of research infrastructure support for my group.</gtr:partnerContribution><gtr:piContribution>My research team has both contributed to and benefited from interactions with colleagues within the MRC Centre for Immune Regulation.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Medical Molecular Virology</gtr:department><gtr:description>MRC Centre for Medical Molecular Virology</gtr:description><gtr:id>2F1603B5-BF06-46D9-9A21-9ED2E932982A</gtr:id><gtr:impact>N/A.</gtr:impact><gtr:outcomeId>MUFfntgxXKS-1</gtr:outcomeId><gtr:partnerContribution>This is a collaborative partnership with regular meetings and a PhD studentship programme.</gtr:partnerContribution><gtr:piContribution>I am a member of the MRC Centre for Medical Molecular Virology at UCL.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press Event for World Diabetes Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FC660708-7B73-4912-A67F-06CB6E758574</gtr:id><gtr:impact>World Diabetes Day (14th November) is commemorated by the world-wide lighting of landmark buildings in blue (the colour of the international diabetes symbol). I organised for Birmingham University's historic clock tower, Old Joe, to be illuminated blue for the evening. The aim of the exercise was to raise awareness of diabetes, in order to encourage screening of at-risk individuals, and also to highlight the research performed by myself and my colleagues at Birmingham University. The event was advertised on the University website in addition to the websites of the Juvenille Diabetes Research Foundation (JDRF) and International Diabetes Federation (IDF). The MRC press office were also notified. A press-release was prepared containing lay summaries of the research performed as part of my MRC Career Development Award along with research performed by my colleagues. The event was attended by local press.

Useful engagement with the local community.</gtr:impact><gtr:outcomeId>0C1BA017EEF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to Sutton Voluntary Group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>43195164-47E8-4D52-A543-6AFE6103163A</gtr:id><gtr:impact>I presented the research goals of my laboratory to Sutton Voluntary Group. This group comprises individuals who have a personal interest in diabetes and raise funds for research in this area.

The group was enthused by our research efforts and requested a return visit for an update next year.</gtr:impact><gtr:outcomeId>FVfAp2pQS2B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Assembly Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>34E1B7F3-477D-4529-9704-DD9EACEC2BCB</gtr:id><gtr:impact>Although it was a sombre event, I received very positive feedback regarding our research efforts.

I was told that people felt very positive about the presentation and it had increased their awareness of the importance of medical research.</gtr:impact><gtr:outcomeId>X2FPyfTXr6v</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute of Immunity &amp; Transplantation Open Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B0A5D068-85C1-44A7-9F08-D28C82425B81</gtr:id><gtr:impact>I gave a presentation on my group's work at the Institute of Immunity &amp;amp; Transplantation Open Day 2015. This event was attended by scientists from throughout the UK as well as industry representatives and members of funding bodies.</gtr:impact><gtr:outcomeId>56d0908963aca3.01726291</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker at ULLA Summer School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1A1A1BDD-E8F1-463D-9165-34325B5EE340</gtr:id><gtr:impact>A group of international PhD students attended the ULLA Diabetes Summer School at UCL to hear about different aspects of diabetes research.

Lots of enthusiasm and interest. A request for a lab placement to learn more about our work.</gtr:impact><gtr:outcomeId>540452aebc9829.57349728</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker at Diabetes UK London Volunteering Event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9BDF53FC-101C-4076-993F-75703868516D</gtr:id><gtr:impact>The talk sparked lots of interest from Diabetes UK supporters and was followed by extensive informal discussions.

Several people said they had a much better idea of what research involved after my talk.</gtr:impact><gtr:outcomeId>562fc3312b49f0.02534262</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Engagement Event for World Diabetes Day</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C52AC71B-F299-4832-BF00-7650F22DB353</gtr:id><gtr:impact>Press event for world diabetes day. The royal free hospital participated in the Blue Monument Challenge organised by the International Diabetes Federation. Purpose: raise awareness of diabetes.

Members of the public became aware that diabetes research was being performed at the royal free hospital.</gtr:impact><gtr:outcomeId>540451864fb586.13236736</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Diabetes Public Engagement Event, Wrexham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FCF746FC-C96A-407B-A6A7-04D289D1A76C</gtr:id><gtr:impact>One of the post-doctoral researchers in my lab gave a presentation to families of children with type 1 diabetes.

Great interest and enthusiasm was shown for our research efforts.</gtr:impact><gtr:outcomeId>s3uQVSiqeQt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lab member speaking at Bromley Diabetes Group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F09D1B16-6DF3-442A-A685-2E55AFA0091F</gtr:id><gtr:impact>The visit was an opportunity for my postdoc to explain our current research into the immunology of Type 1 Diabetes to Bromley Support group, who raise money for diabetes research. The event was enjoyable for everyone and sparked lots of discussion.</gtr:impact><gtr:outcomeId>56d06667933f93.70133607</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>JDRF Parliamentary event</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2CA4C038-4B09-4072-90EA-3EC197D7ED3B</gtr:id><gtr:impact>I attended a JDRF Parliamentary even, hosted by Jamie Reed MP to raise awareness of Type 1 Diabetes. The event included ~100 children and adults affected by type 1 diabetes along with politicians, researchers, healthcare professionals and research funders who came together to celebrate the UK's world-leading role in the fight against the condition.</gtr:impact><gtr:outcomeId>58c2de254c26b3.43358375</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medicine for Members Talk, Royal Free Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>922DB12F-0CD6-4DE2-9B76-AF7D64F5B513</gtr:id><gtr:impact>Approximately 80 members of the public attended an evening talk which was part of the Royal Free Hospital &amp;quot;Medicine for Members&amp;quot; series. These are informal evenings focusing on a particular area of medicine and are open to the public as well as hospital staff. Research performed in the Walker lab was discussed. The talk can be found on youtube at the URL below and has been viewed over 100 times.

The talk raised a great deal of interest and there was an extended session for questions and discussion afterwards.</gtr:impact><gtr:outcomeId>54045475f1ecb2.59149384</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=5utFdrjTJtI</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute opening event</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F65A34BC-1F1E-451C-AF3B-A5EC0C4CA367</gtr:id><gtr:impact>The new Institute for Immunity &amp;amp; Transplantation (opened June 2013) held an opening event for the public, patient groups and other stakeholders. Presentations were given to describe the mission and research goals of the Institute.

The event increased local interest in medical research.</gtr:impact><gtr:outcomeId>VffMFKLvewy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>JDRF Discovery Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>13BBC7AA-1DA1-4DAE-9931-09BC841A247C</gtr:id><gtr:impact>I gave a presentation to a group of diabetic children and their parents at Think Tank Millennium Point in Birmingham. I talked about how my lab is trying to understand what causes type 1 diabetes (using MRC funding as well as funds from JDRF).

Further requests were made to engage with other parent groups.</gtr:impact><gtr:outcomeId>X8vKsM76quX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>JDRF Diabetes Discovery Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>97338A8E-B397-40C5-9342-8982A0961E29</gtr:id><gtr:impact>Dr Rupert Kenefeck, a postdoc in my group, gave a lay presentation about our Type 1 Diabetes research at the JDRF Discovery Day, 9th November, Hertfordshire.

Presentation was well received and resulted in considerable discussion.</gtr:impact><gtr:outcomeId>Xe2HzNR96iH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to Sandwell Diabetes Support Group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FE988779-1E11-40E6-957C-3DE98E6BF09E</gtr:id><gtr:impact>The research talk was well received and generated a lively discussion.

N/A.</gtr:impact><gtr:outcomeId>nZsTEvYzHme</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant, DRWF</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>The Diabetes Research &amp; Wellness Foundation</gtr:fundingOrg><gtr:id>F46847C1-598B-4D97-9889-6BE19FD6B171</gtr:id><gtr:outcomeId>56d08eb4a918e9.71532321</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>279643</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant, Diabetes UK</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:fundingRef>BDA: 15/0005253</gtr:fundingRef><gtr:id>2C120698-A01A-4412-BB25-0B06EAB6357E</gtr:id><gtr:outcomeId>56d08d99b856e9.02930355</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>207509</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant, DUK</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:fundingRef>12/0004477</gtr:fundingRef><gtr:id>065BD65C-DA44-475A-93C0-C18EEB2638E4</gtr:id><gtr:outcomeId>acnP7sV6dpy</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1676980</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2021-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>Ref: MR/N001435/1</gtr:fundingRef><gtr:id>9335E0FA-CFD6-4EA5-8E95-7B35F3415FF9</gtr:id><gtr:outcomeId>56d08d33606a56.96741847</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3354685</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Horizon 2020 Innovative Training Network</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>Grant Agreement Number 675395</gtr:fundingRef><gtr:id>4F918355-B957-49B4-9205-351F78A45B5B</gtr:id><gtr:outcomeId>56d08c3fe75448.71960699</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>648863</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant, BBSRC</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>DAF4CACA-3B1C-45EF-A62C-375694AF12A8</gtr:id><gtr:outcomeId>U4p2JDGjX1u0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>137169</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant, MedImmune Inc</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>MedImmune</gtr:fundingOrg><gtr:id>23D13094-2FD8-4C74-939F-8F2065179D11</gtr:id><gtr:outcomeId>56d08ded68b343.21305927</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>263376</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant, Wellcome Trust</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>0677585B-F339-4D07-B956-BD9005F22189</gtr:id><gtr:outcomeId>qo9TFyxMntu0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>58440</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant, Rosetrees Trust</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>9F49C2E0-3AEE-479F-8254-0089F81017F0</gtr:id><gtr:outcomeId>56d08e7106def0.03831488</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>05116761-7966-4117-97CF-B38A97871EFF</gtr:id><gtr:title>B1 cells promote pancreas infiltration by autoreactive T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6a1660ecca4e0289956781b74f791a"><gtr:id>4d6a1660ecca4e0289956781b74f791a</gtr:id><gtr:otherNames>Ryan GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>kvPExpsHRYh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FE774CD-ACE2-4AA4-86E0-85CB50FCDCDA</gtr:id><gtr:title>IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6eaf4402a8e70057cf6ddba6fa93d371"><gtr:id>6eaf4402a8e70057cf6ddba6fa93d371</gtr:id><gtr:otherNames>Penaranda C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15800_20_22733744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56AECF32-633F-42C0-8CFD-CA2E2D8AE2AE</gtr:id><gtr:title>CD4 T cell differentiation in type 1 diabetes.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/806333cf634d7c3a25064d1081e95c7e"><gtr:id>806333cf634d7c3a25064d1081e95c7e</gtr:id><gtr:otherNames>Walker LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>562fb5835336f6.26151716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DE9A525-35F1-4930-B3EC-BD21F86636BB</gtr:id><gtr:title>Immune regulation by CTLA-4--relevance to autoimmune diabetes in a transgenic mouse model.</gtr:title><gtr:parentPublicationTitle>Diabetes/metabolism research and reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d281f0b3fe264ed5fd8c94381b9806a5"><gtr:id>d281f0b3fe264ed5fd8c94381b9806a5</gtr:id><gtr:otherNames>Wang CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1520-7552</gtr:issn><gtr:outcomeId>JgNgKozwhC3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD64527F-0FB0-4771-94CD-313C7F3A6D3E</gtr:id><gtr:title>CD28 costimulation: walking the immunological tightrope.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2e46885d82d9619ed85a74c89c393f"><gtr:id>9a2e46885d82d9619ed85a74c89c393f</gtr:id><gtr:otherNames>Sansom DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_15800_20_23322693</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>266D1917-36D9-4572-80A7-724A1D40A350</gtr:id><gtr:title>Confusing signals: recent progress in CTLA-4 biology.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/806333cf634d7c3a25064d1081e95c7e"><gtr:id>806333cf634d7c3a25064d1081e95c7e</gtr:id><gtr:otherNames>Walker LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>562fb5840212f6.11283273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F105B10-3235-4E48-86CA-FE702B07407A</gtr:id><gtr:title>B cell depletion in autoimmune diabetes: insights from murine models.</gtr:title><gtr:parentPublicationTitle>Expert opinion on therapeutic targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/556e9a694d507489a7da775149061202"><gtr:id>556e9a694d507489a7da775149061202</gtr:id><gtr:otherNames>Chamberlain JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1472-8222</gtr:issn><gtr:outcomeId>i2hFGGfZEf3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1345DA83-345C-4564-9B9A-8D560B970D60</gtr:id><gtr:title>The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/806333cf634d7c3a25064d1081e95c7e"><gtr:id>806333cf634d7c3a25064d1081e95c7e</gtr:id><gtr:otherNames>Walker LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>Xvd7DtevjDW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4526A8F3-A0B2-40E6-BD9F-76AE3973637F</gtr:id><gtr:title>Cutting edge: cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d281f0b3fe264ed5fd8c94381b9806a5"><gtr:id>d281f0b3fe264ed5fd8c94381b9806a5</gtr:id><gtr:otherNames>Wang CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_15800_20_22753931</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A4E20C0-39FF-429A-BC13-86B69CB41CAE</gtr:id><gtr:title>T-Regulatory Cells and Inflammatory and Inhibitory Cytokines in Malawian Children Residing in an Area of High and an Area of Low Malaria Transmission During Acute Uncomplicated Malaria and in Convalescence.</gtr:title><gtr:parentPublicationTitle>Journal of the Pediatric Infectious Diseases Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/055d643d74a6f2eeab718f945be2a21a"><gtr:id>055d643d74a6f2eeab718f945be2a21a</gtr:id><gtr:otherNames>Nyirenda TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2048-7193</gtr:issn><gtr:outcomeId>562fb5837d1db3.23281229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41C48EE6-CBD4-47C7-824B-E8969981D557</gtr:id><gtr:title>IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77a1ebf3e4e23d076862c3474ea9bba8"><gtr:id>77a1ebf3e4e23d076862c3474ea9bba8</gtr:id><gtr:otherNames>Attridge K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_15800_20_22442347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C632CC34-652C-4537-A62D-946CDF4BD31C</gtr:id><gtr:title>Regulatory T Cells in Autoimmune Diabetes: Mechanisms of Action and Translational Potential.</gtr:title><gtr:parentPublicationTitle>Progress in molecular biology and translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4c07a367e39558a8561a1d0690a383a"><gtr:id>b4c07a367e39558a8561a1d0690a383a</gtr:id><gtr:otherNames>Ovcinnikovs V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1877-1173</gtr:issn><gtr:outcomeId>56d0690567f013.87503384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42E29A5A-6545-40A6-989C-E211832176F4</gtr:id><gtr:title>A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85bd3bae78ebfd9614186f8b8e263206"><gtr:id>85bd3bae78ebfd9614186f8b8e263206</gtr:id><gtr:otherNames>Hou TZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>562fb583a37082.06645000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5E29A47-F08D-4610-8408-E9BD68883063</gtr:id><gtr:title>CTLA-4 and Autoimmunity: New Twists in the Tale.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/806333cf634d7c3a25064d1081e95c7e"><gtr:id>806333cf634d7c3a25064d1081e95c7e</gtr:id><gtr:otherNames>Walker LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>56d06905357641.25973707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C7C0BA4-5A46-4293-822D-FFB7163B9E4B</gtr:id><gtr:title>Maintaining a competitive edge: new rules for peripheral T cell homeostasis.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/806333cf634d7c3a25064d1081e95c7e"><gtr:id>806333cf634d7c3a25064d1081e95c7e</gtr:id><gtr:otherNames>Walker LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>pm_15800_20_23084356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88188AFA-AED9-4E39-AFEF-6A5FAFFBF5D7</gtr:id><gtr:title>Follicular helper T cell signature in type 1 diabetes.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc90e7d6e7df502acf92dd6c5052023c"><gtr:id>fc90e7d6e7df502acf92dd6c5052023c</gtr:id><gtr:otherNames>Kenefeck R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>562fb5842a21d9.89545204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9957BD62-5099-411F-8406-4FCCC4BE3CAB</gtr:id><gtr:title>Contemplating autoimmunity in the Aegean islands.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/806333cf634d7c3a25064d1081e95c7e"><gtr:id>806333cf634d7c3a25064d1081e95c7e</gtr:id><gtr:otherNames>Walker LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>56d06905982287.61400859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D55C9A34-2D99-445F-B643-B45AFE50D37B</gtr:id><gtr:title>Treg and CTLA-4: two intertwining pathways to immune tolerance.</gtr:title><gtr:parentPublicationTitle>Journal of autoimmunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/806333cf634d7c3a25064d1081e95c7e"><gtr:id>806333cf634d7c3a25064d1081e95c7e</gtr:id><gtr:otherNames>Walker LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0896-8411</gtr:issn><gtr:outcomeId>pm_15800_20_23849743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FA7BC7B-C5B1-4EE5-B62A-5B1EACE07B6E</gtr:id><gtr:title>IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77a1ebf3e4e23d076862c3474ea9bba8"><gtr:id>77a1ebf3e4e23d076862c3474ea9bba8</gtr:id><gtr:otherNames>Attridge K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>54044d808f3e76.37733801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A13B13F1-C289-4F6C-A398-632BF23F32DB</gtr:id><gtr:title>Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77a1ebf3e4e23d076862c3474ea9bba8"><gtr:id>77a1ebf3e4e23d076862c3474ea9bba8</gtr:id><gtr:otherNames>Attridge K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>54044d804c3757.72521876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54B35B58-04B7-474A-B08E-9F958012F708</gtr:id><gtr:title>CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d281f0b3fe264ed5fd8c94381b9806a5"><gtr:id>d281f0b3fe264ed5fd8c94381b9806a5</gtr:id><gtr:otherNames>Wang CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>562fb583d04679.82029035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04920A8E-7752-4F5B-A4FA-2FECBC4D810C</gtr:id><gtr:title>Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2d119d2d28732637a596a12677acdfb"><gtr:id>c2d119d2d28732637a596a12677acdfb</gtr:id><gtr:otherNames>Gaspal F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>Kay8TqUkRcY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37098BA3-D347-430A-8846-3FDF2CE82F36</gtr:id><gtr:title>Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e25301d9343474ed0cb11fb61662443"><gtr:id>6e25301d9343474ed0cb11fb61662443</gtr:id><gtr:otherNames>Qureshi OS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>kcgZBb3o4PP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6FC24BC-608C-4AC3-9B61-BE95FA68871C</gtr:id><gtr:title>Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory disease.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ac0822fe925fdd1d749368b83a0d1ed"><gtr:id>0ac0822fe925fdd1d749368b83a0d1ed</gtr:id><gtr:otherNames>Chimen M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>doi_55f984984f881fbb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4199D6C4-A441-4E19-9710-56C8CD34B78C</gtr:id><gtr:title>Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ed5b82310774f9fc3e63fcbd597bb20"><gtr:id>2ed5b82310774f9fc3e63fcbd597bb20</gtr:id><gtr:otherNames>Schubert D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>544d4eac7c7104.42778510</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802382</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>